Cambrex Advances US and European Expansions

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

CAMBREX

More Like This

PR Newswire associated0

Cambrex Unveils $120 Million Investment to Expand API Manufacturing and Strengthen U.S. Drug Supply Resilience

PR Newswire associated0

Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule

PR Newswire associated0

Cambrex Completes $38 Million Capacity Expansion in High Point, North Carolina

PR Newswire associated0

Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts

PR Newswire associated0

Cambrex Announces Sale of Drug Product Business Unit

PR Newswire associated0

Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing

PR Newswire associated0

Cambrex Announces New Liquid-Phase Peptide Synthesis Manufacturing Technology

PR Newswire associated0

Snapdragon Chemistry, a Cambrex Company, Recognized with CPhI Pharma Award for API Development